Portrait Vaecgene focuses on the r&d of new diagnostics and therapeutics. Proprietary technologies consist of a own target technology for functional proteomics (AMIDA) for fast and efficient identification and validation of tumor markers for early detection of cancer. In addition, the company offers services related to Epstein-Barr Virus as well as the generation of specific T lymphocytes for e.g. adoptive transfer.